Why we should be vigilant: drug cytotoxicity observed with in vitro transporter inhibition studies.

[1]  P. Boutros,et al.  Differential interactions between statins and P‐glycoprotein: Implications for exploiting statins as anticancer agents , 2010, International journal of cancer.

[2]  Sean Ekins,et al.  Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. , 2009, Molecular pharmaceutics.

[3]  Sean Ekins,et al.  Novel Inhibitors of Human Organic Cation/Carnitine Transporter (hOCTN2) via Computational Modeling and In Vitro Testing , 2009, Pharmaceutical Research.

[4]  C. Tse,et al.  Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[5]  J. Polli,et al.  Method to Screen Substrates of Apical Sodium-Dependent Bile Acid Transporter , 2008, The AAPS Journal.

[6]  Kristin E. D. Coan,et al.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. , 2008, Journal of the American Chemical Society.

[7]  D. Putt,et al.  Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells. , 2008, Toxicology.

[8]  Jean M. Severin,et al.  Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance. , 2007, Chemical research in toxicology.

[9]  C. Tse,et al.  Inhibition of human equilibrative nucleoside transporters by dihydropyridine-type calcium channel antagonists. , 2007, European journal of pharmacology.

[10]  H. Koepsell,et al.  Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications , 2007, Pharmaceutical Research.

[11]  Jeffrey R. Huth,et al.  Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups , 2007, J. Comput. Aided Mol. Des..

[12]  Sean Ekins,et al.  Pharmacophore-based discovery of ligands for drug transporters. , 2006, Advanced drug delivery reviews.

[13]  H. Sakagami,et al.  Cytotoxic potential of phenothiazines. , 2006, Current drug targets.

[14]  Masaki Kobayashi,et al.  Inhibitory effects of statins on human monocarboxylate transporter 4. , 2006, International journal of pharmaceutics.

[15]  Suneet Shukla,et al.  The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2. , 2006, Biochemistry.

[16]  Yi Zhang,et al.  BCRP Transports Dipyridamole and is Inhibited by Calcium Channel Blockers , 2005, Pharmaceutical Research.

[17]  M. Morris,et al.  Effects of new 4-aryl-1,4-dihydropyridines and 4-arylpyridines on drug efflux mediated by multidrug resistance-associated protein 1. , 2005, Journal of pharmaceutical sciences.

[18]  J. Polli,et al.  Development of Stably Transfected Monolayer Overexpressing the Human Apical Sodium-Dependent Bile Acid Transporter (hASBT) , 2005, Pharmaceutical Research.

[19]  J. Kimura,et al.  Down-Regulation of Na+/Ca2+ Exchanger by Fluvastatin in Rat Cardiomyoblast H9c2 Cells: Involvement of RhoB in Na+/Ca2+ Exchanger mRNA Stability , 2005, Molecular Pharmacology.

[20]  T. Smart,et al.  HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.

[21]  Sean Ekins,et al.  In Vitro and Pharmacophore-Based Discovery of Novel hPEPT1 Inhibitors , 2005, Pharmaceutical Research.

[22]  Peter Pennefather,et al.  Peroxidase catalysed formation of cytotoxic prooxidant phenothiazine free radicals at physiological pH. , 2004, Chemico-biological interactions.

[23]  F. Lang,et al.  Stimulation of the EAAT4 glutamate transporter by SGK protein kinase isoforms and PKB. , 2004, Biochemical and biophysical research communications.

[24]  Y. Shinohara,et al.  Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes , 2004, Cancer Chemotherapy and Pharmacology.

[25]  Maristela L Onozato,et al.  Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. , 2004, European journal of pharmacology.

[26]  M. Gobbi,et al.  Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerations. , 2003, European journal of pharmacology.

[27]  B. Shoichet,et al.  Identification and prediction of promiscuous aggregating inhibitors among known drugs. , 2003, Journal of medicinal chemistry.

[28]  H. Ohba,et al.  Effect of phenothiazines on protein kinase C- and calcium-dependent activation of peritoneal macrophages , 2003, Cell Biology and Toxicology.

[29]  U. Kang,et al.  Induction of Early Growth Response-1 Gene Expression by Calmodulin Antagonist Trifluoperazine through the Activation of Elk-1 in Human Fibrosarcoma HT1080 Cells* , 2001, The Journal of Biological Chemistry.

[30]  J. Rothstein,et al.  Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins , 2001, Nature.

[31]  H. Yamazaki,et al.  Inhibitory Potencies of 1,4-dihydropyridine Calcium Antagonists to P-glycoprotein-Mediated Transport: Comparison with the Effects on CYP3A4 , 2000, Pharmaceutical Research.

[32]  B. Rothen‐Rutishauser,et al.  Cell cultures as tools in biopharmacy. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[33]  H. Matter,et al.  Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na(+)/bile acid cotransporter. , 1999, Journal of lipid research.

[34]  Abraham Weizman,et al.  Effects of psychotropic drugs on cell proliferation and differentiation. , 1999, Biochemical pharmacology.

[35]  P. Dawson,et al.  Bile Acid Uptake via the Human Apical Sodium-Bile Acid Cotransporter Is Electrogenic* , 1998, The Journal of Biological Chemistry.

[36]  J. Nezu,et al.  Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2* , 1998, The Journal of Biological Chemistry.

[37]  Y. Tsujimoto,et al.  Intracellular ATP levels determine cell death fate by apoptosis or necrosis. , 1997, Cancer research.

[38]  K. Jacobson,et al.  Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors. , 1996, Journal of medicinal chemistry.

[39]  P. Dawson,et al.  Identification of a Mutation in the Ileal Sodium-dependent Bile Acid Transporter Gene That Abolishes Transport Activity (*) , 1995, The Journal of Biological Chemistry.

[40]  K. Fukuchi,et al.  Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds. , 1995, Anticancer research.

[41]  M. Kavanaugh,et al.  An excitatory amino-acid transporter with properties of a ligand-gated chloride channel , 1995, Nature.

[42]  A. Chipperfield,et al.  Ouabain Binding to the Sodium Pump , 1973, Nature.